Literature DB >> 11961697

HIV Vaccine Trial participation in South Africa - an ethical assessment.

Keymanthri Moodley1.   

Abstract

Trial participation in the proposed HIV Vaccine Trials in South Africa is discussed in the context of the ethical tension that exists between international ethical research standards and local standards of care and cultural norms in the Third World. The important concepts of informed consent, risk-benefit ratio and fair treatment of trial participants are interpreted differently in traditional, rural African communities, where a moderate form of communitarianism referred to as "Ubuntu" or "communalism" is still prevalent. Research is an altruistic endeavor that benefits communities and societies as a result of risks taken by individuals. Universal ethical guidelines that are highly individualistic and fail to emphasize communalism may represent serious problems for the sort of research needed in Africa today.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2002        PMID: 11961697     DOI: 10.1076/jmep.27.2.197.2986

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  6 in total

1.  Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in Western Kenya.

Authors:  D N Shaffer; V N Yebei; J B Ballidawa; J E Sidle; J Y Greene; E M Meslin; S J N Kimaiyo; W M Tierney
Journal:  J Med Ethics       Date:  2006-01       Impact factor: 2.903

2.  HIV practitioners in Madrid and New York improving inclusion of underrepresented populations in research.

Authors:  Rogério M Pinto; Silvia Giménez; Anya Y Spector; Jean Choi; Omar J D Martinez; Melanie Wall
Journal:  Health Promot Int       Date:  2014-03-27       Impact factor: 2.483

Review 3.  Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Authors:  Joalida Smit; Keren Middelkoop; Landon Myer; Graham Lindegger; Leslie Swartz; Soraya Seedat; Tim Tucker; Robin Wood; Linda-Gail Bekker; Dan J Stein
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 4.  Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation.

Authors:  Muhammed O Afolabi; Jane U Adetifa; Egeruan B Imoukhuede; Nicola K Viebig; Beate Kampmann; Kalifa Bojang
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

5.  "On the last day of the last month, I will go": A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults.

Authors:  Natalie J Tibbels; Abdul Dosso; Corinne Fordham; William Benie; Jeanne Aka Brou; Diarra Kamara; Zoé M Hendrickson; Danielle A Naugle
Journal:  Vaccine       Date:  2022-02-11       Impact factor: 4.169

6.  Microbicide research in developing countries: have we given the ethical concerns due consideration?

Authors:  Keymanthri Moodley
Journal:  BMC Med Ethics       Date:  2007-09-19       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.